Form 4: Aveanna Healthcare Holdings: J.H. Whitney Affiliates Execute Stock Sales Under 10b5-1 Plan
SEC Form 4 Filing
Robert M. Williams Jr., along with affiliated entities of J.H. Whitney, reported the sale of Aveanna Healthcare Holdings (AVAH) common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, Inc. (AVAH), and related entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC, reported sales of AVAH common stock.
- The sales occurred on March 18 and 19, 2025, at weighted average prices of $5.51 and $5.46 per share, respectively.
- These transactions were executed automatically under a Rule 10b5-1 trading plan adopted on December 13, 2024.
- The total number of shares sold by the entities was 149,491.
- Following these transactions, J.H. Whitney VII, L.P. beneficially owns 31,388,159 shares, PSA Healthcare Investment Holding LLC beneficially owns 15,681,861 shares, JHW Iliad Holdings LLC beneficially owns 5,213,094 shares, PSA Iliad Holdings LLC beneficially owns 1,451,778 shares and JHW Iliad Holdings II LLC beneficially owns 546,457 shares.
- Robert M. Williams, Jr. disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock sales by insiders. It doesn't inherently convey positive or negative sentiment, but the ongoing sales could be interpreted as slightly negative.
Risks
- Continued sales under the 10b5-1 plan could exert downward pressure on the stock price.
Future Outlook
The document does not contain any specific forward-looking statements or guidance regarding Aveanna Healthcare Holdings.
Industry Context
Form 4 filings are standard disclosures for insiders selling company stock; the use of a 10b5-1 plan suggests the sales were pre-planned and intended to avoid accusations of insider trading. The size of the sales is relatively small compared to the overall holdings of the entities involved.
Stakeholder Impact
- The stock sales could potentially impact shareholder value if they contribute to downward pressure on the stock price.
- The impact on other stakeholders (employees, customers, suppliers, creditors) is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Date of adoption of the Rule 10b5-1 trading plan by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC and JHW Iliad Holdings II LLC. |
| 2025-03-18 | Date of first reported stock sale at a weighted average price of $5.51. |
| 2025-03-19 | Date of second reported stock sale at a weighted average price of $5.46. |
| 2025-03-20 | Date of signature of the Form 4 filings by Robert M. Williams, Jr. |
Keywords
Aveanna Healthcare Holdings, AVAH, Robert M. Williams Jr., J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, JHW Iliad Holdings II LLC, Stock Sale, Form 4, Rule 10b5-1 Trading Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.